Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
Sell
24
CDCTF Quote, Financials, Valuation and Earnings
Last price:
$12.72
Seasonality move
:
-8.49%
Day range:
$12.72 - $12.72
52-week range:
$12.72 - $12.72
Dividend yield:
4.25%
P/E ratio:
11.91x
P/S ratio:
2.17x
P/B ratio:
0.46x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$422.8M
Revenue:
$172.2M
EPS (TTM):
$1.07
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Goldcrest has -- downside to fair value with a price target of -- per share.
CDCTF vs. S&P 500
-
Over the past 5 trading days, Goldcrest has underperformed the S&P 500 by -1.85% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Goldcrest does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Goldcrest has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Goldcrest reported revenues of $43.2M.
Earnings Growth
-
Goldcrest has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Goldcrest reported earnings per share of $0.22.
Enterprise value:
297.3M
EV / Invested capital:
--
Price / LTM sales:
2.17x
EV / EBIT:
5.72x
EV / Revenue:
1.53x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
-3.69x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
5.72x
Gross Profit (TTM):
$94.4M
Return On Assets:
2.72%
Net Income Margin (TTM):
18.25%
Return On Equity:
2.79%
Return On Invested Capital:
2.91%
Operating Margin:
26.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $367M | $109.2M | $194.5M | $18.5M | $43.2M | |
| Gross Profit | $192.7M | $51.7M | $94.4M | $8.5M | $22.2M | |
| Operating Income | $152.8M | $11.5M | $51.6M | -$1.5M | $11.4M | |
| EBITDA | $154.7M | $13.2M | $51.9M | -$1.4M | $11.4M | |
| Diluted EPS | $2.89 | $0.29 | $1.07 | -$0.09 | $0.22 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.3B | $1.1B | $1.1B | $1.1B | |
| Total Assets | $1.7B | $1.7B | $1.3B | $1.3B | $1.4B | |
| Current Liabilities | $162.1M | $88.8M | $84.4M | $184.9M | $100.2M | |
| Total Liabilities | $599M | $584.3M | $426.1M | $397.9M | $441M | |
| Total Equity | $1.1B | $1.1B | $905M | $863.8M | $927.5M | |
| Total Debt | $506M | $468.3M | $338.3M | $326.8M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-03-31 | 2010-03-31 | 2011-03-31 | 2010-03-31 | 2011-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $223.8M | -$78.6M | $23.7M | -$9.1M | |
| Cash From Investing | -- | -$158.7K | $91.5M | $352.9K | -$5.9M | |
| Cash From Financing | -- | -$76.6M | -$315.5M | $2.3M | -$178.8M | |
| Free Cash Flow | -- | $222.9M | -$80.6M | $23.7M | -$11M | |
CDCTF
Sector
Market Cap
$422.8M
$1B
Price % of 52-Week High
100%
82.19%
Dividend Yield
4.25%
3.24%
Shareholder Yield
--
3.36%
1-Year Price Total Return
--
-2.83%
Beta (5-Year)
-0.058
0.887
Dividend yield:
4.25%
Annualized payout:
$0.53
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$12.72
200-day SMA
Sell
Level
$12.72
Bollinger Bands (100)
Sell
Level
12.72 - 12.72
Chaikin Money Flow
Sell
Level
-3.4K
20-day SMA
Sell
Level
$12.72
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
40.58
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$12.72
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-5.4K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2753)
Buy
CA Score
(Annual)
Level (0.4837)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.9026)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Goldcrest Co Ltd is a property development company. It is engaged in the development and sale of condominiums in and around the Tokyo Metropolitan Area. The Company operates in three business segments such as Real Estate Sales, Real Estate Leasing, and Others. The Real Estate Sales segment deals with the development and marketing of condominiums such as Crest City, Crest Form series and Crest Residence. The Real Estate Leasing segment involves with office building and apartment leasing activities. The others segment offers real estate management services.
Stock Forecast FAQ
In the current month, CDCTF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CDCTF average analyst price target in the past 3 months is --.
-
Where Will Goldcrest Stock Be In 1 Year?
According to analysts, the consensus estimate is that Goldcrest share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Goldcrest?
Analysts are divided on their view about Goldcrest share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Goldcrest is a Sell and believe this share price will rise from its current level to --.
-
What Is Goldcrest's Price Target?
The price target for Goldcrest over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CDCTF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Goldcrest is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CDCTF?
You can purchase shares of Goldcrest via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Goldcrest shares.
-
What Is The Goldcrest Share Price Today?
Goldcrest was last trading at $12.72 per share. This represents the most recent stock quote for Goldcrest. Yesterday, Goldcrest closed at $12.72 per share.
-
How To Buy Goldcrest Stock Online?
In order to purchase Goldcrest stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Will Sirius XM Be a 10-Bagger Stock?
Last year, Warren Buffett surprised practically everyone when he acquired…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is up 7.59% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 0.28% over the past day.
Buy
51
GH alert for Jan 22
Guardant Health [GH] is up 5.72% over the past day.
